August 27th, 2021 by Chassin
A clinical research study is currently recruiting adults
Ages 18-65 with a diagnosis of alopecia areata
Who have lost 50% or more of the hair on their head
To participate in a study of an oral investigational drug.
For more details visit the U.S. National Library of Medicine’s Clinical Trials website.
Bald Girls Do Lunch is providing this announcement for informational purposes only. Bald Girls Do Lunch does not imply endorsement. The decision to participate is voluntary and wholly the responsibility of the individual person.
Posted in 2021, alopecia areata, clinical trials, Concert Pharmaceuticals, CPT-543, JAK Inhibitor, research
March 24th, 2021 by Chassin
A clinical research study is currently recruiting adults in the US and Canada.
The preliminary requirements to participate in this study of an oral investigational drug are:
- • Adults ages 18-65
- • A diagnosis of alopecia areata
- • 50% or greater scalp hair loss
For more detailed clinical information visit https://bgdl.org/THRIVE-AA1.
Bald Girls Do Lunch is providing this announcement for informational purposes only. Bald Girls Do Lunch does not imply endorsement. The decision to participate is voluntary and wholly the responsibility of the individual person.
Posted in 2021, clinical trials, JAK Inhibitor, research
September 30th, 2020 by Chassin
Arena Pharmaceuticals is recruiting for a clinical trial in multiple locations. Complete this form , AA-205 online screener, to apply for the trial “Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata.” The screener form has been prepared for Arena by Innovaderm Research.
- • You’re between 18 and 70 years old.
- • You have current alopecia areata with hair loss that affects at least 50% of your scalp.
- • Your current hair loss episode has been lasting for more than 6 months, but less than eight years.
Learn more about Arena Phamaceutical’s trial with oral Etrasimod and the study locations on the application form.
You may be compensated for time and travel. Talk to your personal doctor before joining a clinical trial. Bald Girls Do Lunch is providing this announcement for informational uses only. It does not imply endorsement. The decision to participate is voluntary and wholly the responsibility of the individual person.
For more detailed clinical information visit clinicaltrials.gov.
Posted in 2020, alopecia areata, clinical trials, Medical
April 23rd, 2016 by Chassin
Mount Sinai ( New York ) has options for alopecia areata patients
Is there a cure for alopecia areata? No, there is no cure, but researchers are doing clinical trials in search of safe and effective alopecia treatments. Dr. Emma Guttman, in New York is conducting several studies including a pilot study with Tralokinumab for moderate to severe alopecia areata.
Follow along with our interview so you can talk to your friends and family about new studies for alopecia treatment…Â Read More
Posted in 2016, alopecia areata, clinical trials, research, topical treatments
March 18th, 2016 by Chassin
Alopecia Areata research is of great interest to people with this autoimmune skin disorder. This Bald Girls Do Lunch blog informs you with patient-friendly posts on alopecia areata news, clinical trials and popular posts like our features on Tofacitinib and Ruxolitinib. In 2016…Read More
Posted in 2016, alopecia areata, clinical trials, research, topical treatments, Treatments
